Stories
Slash Boxes
Comments

SoylentNews is people

posted by CoolHand on Wednesday August 31 2016, @05:37AM   Printer-friendly
from the tonight-they're-going-to-pollute-like-its-1999 dept.

Both houses of the California legislature have passed a bill called SB-32 which would tell the California Air Resources Board "to ensure that statewide greenhouse gas emissions are reduced to 40% below the 1990 level by 2030." The state's Democratic governor has issued a statement indicating that he intends to sign it into law.

The Western States Petroleum Association and the California Manufacturers & Technology Association expressed their opposition to the bill.

links:


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 5, Insightful) by Oakenshield on Wednesday August 31 2016, @12:03PM

    by Oakenshield (4900) on Wednesday August 31 2016, @12:03PM (#395650)

    Economic fun fact... prices are set by the buyer, not the seller.

    You fail basic economics. Pricing is set by a meeting of the minds between buyer and seller. A seller can refuse to sell if the buyer is unwilling to pay the price desired and the buyer can refuse to buy if the seller sets the price too high.

    Do you really think they would stop making epi-pens if no-one would spend more then $5 for it?

    Yes. I am certain that there is more than $5 in governmental regulation involved. The Auvi-Q (epipen clone) left a market with a gigantic profit margin over a dosing problem recall. The cost of Asthma drugs skyrocketed in recent years when the FDA banned all CFC propellants in drugs causing manufacturers to have to go through the process of recertifying old drugs with new delivery methods. Albuterol which had been generic for years tripled overnight when generics disappeared despite the fact the drug did not change. GlaxoSmithKline is one of the most profitable pharma companies in the world because of Advair/Seretide despite the drug being off patent for years. The delivery device is the sticking point.

    The problem is that there are people whose lives depend on the epipen. That makes it very valuable to them. The question is, should we as a soceity allow pharmaceutical companies to take advantage of that demand in order to maximize profits? I believe that we are finally seeing a shift in public opinion. Now, will government actually do anything about it, or will lobbyists win again?

    Starting Score:    1  point
    Moderation   +4  
       Insightful=3, Informative=1, Total=4
    Extra 'Insightful' Modifier   0  

    Total Score:   5  
  • (Score: 0) by Anonymous Coward on Wednesday August 31 2016, @01:53PM

    by Anonymous Coward on Wednesday August 31 2016, @01:53PM (#395674)

    > Now, will government actually do anything about it, or will lobbyists win again?

    They will always win. The question is how much will they win. And that answer is directly correlated with campaign finance. I don't mean quid-pro-quo (as the simpleton Trump has alleged) but rather access. When politicians have to spend 40% of their time every week talking to assholes with money they end up living in an information bubble largely defined by those assholes. They don't deliberately do favors for those asshole, they just never hear any other sides of the story. Kind of like a child raised by ultra religious parents- all they ever hear are stories about jeebus so it is extremely difficult for them to even conceive that there are other perspectives.